HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Prenalterol Hydrochloride

HCID 43590
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
61260-05-7
Standard SMILES
CC(C)NC[C@H](O)COc1ccc(O)cc1.Cl
InChIKey
WDXYIFGETVGLBZ-MERQFXBCSA-N
Molecular formula
C12H20ClNO3
Average molar mass
261.74 g/mol
Monoisotopic mass
261.1131712

Overview

See also: Prenalterol (has active moiety).

Names & identifiers

Preferred name
Prenalterol Hydrochloride
IUPAC
4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenol;hydrochloride

Names & synonyms

PRENALTEROL HYDROCHLORIDEPrenalterol HCl61260-05-7CGP 7760BU6VH18LCQ8CGP-7760BH 133/22DTXSID40210161H-133/22Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, hydrochloride, (S)-RefChem:175875Hydrochloride, Prenalterol
Show more names
DTXCID40132652262-676-5Prenalterol hydrochloride [USAN](-)-(S)-1-(p-Hydroxyphenoxy)-3-(isopropylamino)-2-propanol hydrochloridePrenalterol hydrochloride (USAN)UNII-U6VH18LCQ8EINECS 262-676-5SCHEMBL121857

Database identifiers

CAS
61260-05-7
PubChem CID
43590
DTXSID
DTXSID40210161
ChEMBL
CHEMBL3085478
UNII
U6VH18LCQ8
EC Number
262-676-5

Properties

Computed structural properties

Topological polar surface area
61.7 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
4
Rotatable bonds
6
Heavy atoms
17
Formal charge
0
Complexity
179

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Other Safety InformationIMAP assessments - Phenol, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, hydrochloride, (S)-: Environment tier I assessment

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes